AKT1 and glioma: Human mAbs against DR5 (E11, H48, and KMTR2) showed cytotoxicity, as well as tumor regression effects in human glioma cells by inducing apoptosis, with no effect on normal astrocytes, by downregulating c-FLIPL and AKT [332].